UNSPSC 51332004: Sertindole
Commodity
Code facts
- Part of
-
-
51000000
-
51330000
- 51332000
-
51330000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51332004
Definition
This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C24H26ClFN4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GVV4Z879SP, chemically known as 2-imidazolidinone, 1-(2-(4-(5-chloro-1-(4-fluorophenyl)-1h-indol-3-yl)-1-piperidinyl)ethyl)- but generally known as sertindole, which bears US NIH Compound Identifier 60149. European Medicines Agency schedules Sertindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10498MIG.
Read the full definition
The term SERTINDOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules sertindole in its Anatomical Therapeutic Chemical (ATC) Classification. SERTINDOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule sertindole under HS 29333999 and SITC 51574. As of Q4 2014, SERTINDOLE remains the US FDA Preferred Term for this commodity. Sertindole bears US NLM identifiers UMLS ID C0084528 and NCI Concept Code C73295.
SMILES: CLC1CC2C(C3CCN(CC3)CCN3CCNC3=O)CN(C2CC1)C1CCC(F)CC1.
About UNSPSC 51332004
UNSPSC 51332004 Sertindole is a Commodity code that maps to pharmaceutical procurement, though the recent state and local solicitation activity under this code shows a mismatch with the nominal product name. The single recent opportunity tagged to this code concerns naloxone and drug deactivation systems rather than sertindole specifically, suggesting either a cataloging inconsistency or a broader application of the code to opioid-response and harm-reduction pharmaceuticals and equipment. State and local governments buying under this code are procuring naloxone (a medication for opioid overdose reversal) and complementary safe drug deactivation systems to support community health and public safety initiatives. The issuing bodies appear to be county health departments and public health agencies focused on substance-abuse response and emergency preparedness.
The geographic data is limited to a single recent opportunity. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation closed on July 26, 2023, at 2:00 pm. The contract included a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance, drug-free workplace certification, and standard insurance requirements including workers' compensation, commercial general liability, and professional liability. FEMA funding was potentially involved, triggering additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Recent solicitation activity under this code is sparse; the single identified opportunity is the only recent market signal available for evaluation.
Quick answers
What is UNSPSC 51332004?
UNSPSC 51332004 is Sertindole, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51332004?
UNSPSC 51332004 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51332004
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code